Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
765
Views
12
CrossRef citations to date
0
Altmetric
Author's View

Adaptive immune resistance in HPV-associated head and neck squamous cell carcinoma

Sara I. Pai Department of Otolaryngology-Head and Neck Surgery; Johns Hopkins University School of Medicine; Baltimore, MD USA; Department of Oncology; Johns Hopkins University School of Medicine; Baltimore, MD USACorrespondence[email protected]
Article: e24065 | Received 19 Feb 2013, Accepted 21 Feb 2013, Published online: 01 May 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiongwen Ran & Kai Yang. (2017) Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives. Drug Design, Development and Therapy 11, pages 2007-2014.
Read now

Articles from other publishers (11)

Robert L. FerrisWilliam Westra. (2023) Oropharyngeal Carcinoma with a Special Focus on HPV-Related Squamous Cell Carcinoma. Annual Review of Pathology: Mechanisms of Disease 18:1, pages 515-535.
Crossref
A. I.  Stukan, R.  A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov & V. A. Porkhanov. (2022) Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender. Head and Neck Tumors (HNT) 12:3, pages 114-126.
Crossref
Efthymia Soura, Eleni Gagari & Alexander Stratigos. (2019) Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?. Current Opinion in Oncology 31:5, pages 461-468.
Crossref
Ilson Sepulveda, Rodrigo Ascui & A. Andrés Capizzano. (2019) Checkpoint inhibitors in head and neck cancer. memo - Magazine of European Medical Oncology 12:3, pages 249-252.
Crossref
Alessandro Guidi, Carla Codecà & Daris Ferrari. (2018) Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review. Medical Oncology 35:3.
Crossref
S. Lang, S. Mattheis & B. Kansy. 2017. HPV Infection in Head and Neck Cancer. HPV Infection in Head and Neck Cancer 207 218 .
Teresa Fu, Sumaira Z. Aasi & S. Tyler Hollmig. (2016) Management of High-Risk Squamous Cell Carcinoma of the Skin. Current Treatment Options in Oncology 17:7.
Crossref
Pavlos Msaouel & Erminia Massarelli. (2016) Immune Checkpoint Therapy in Head and Neck Cancers. The Cancer Journal 22:2, pages 108-116.
Crossref
Benjamin A. Kansy, Nicole C. Schmitt & Robert L. Ferris. (2015) Immune Escape and Immunotherapy of HPV-Related Oropharyngeal Cancer: Has the Future Arrived?. Current Otorhinolaryngology Reports 3:2, pages 63-72.
Crossref
Daniel Lee Miller & M. Sharon Stack. 2015. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer 133 152 .
Nicole C. Schmitt, Robert L. Ferris & Seungwon Kim. 2015. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer 291 306 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.